Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03060434
PHASE4

Pentoxifylline and Lumbar Radiculopathy

Sponsor: St Joseph University, Beirut, Lebanon

View on ClinicalTrials.gov

Summary

The objective of this prospective controlled crossover study is to evaluate the efficacy and safety of pentoxifylline per os (800 mg daily) in the management of lumbar radiculopathy

Official title: Prospective Controlled Crossover Study of the Role of Pentoxifylline in the Management of Lumbar Radiculopathy

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

67

Start Date

2018-06-01

Completion Date

2026-12-01

Last Updated

2025-05-21

Healthy Volunteers

No

Interventions

DRUG

Pentoxifylline Oral Tablet

patient will receive for 15 days: Ibuprofen 600 mg bid; pregabalin 75 mg bid; paracetamol 1 g tid; pentoxifylline 400 mg bid

DRUG

Ibuprofen

patient will receive for 15 days: Ibuprofen 600 mg bid; pregabalin 75 mg bid; paracetamol 1 g tid

Locations (1)

Hotel Dieu de France Hospital

Beirut, Lebanon